EC Number |
Title |
Organism |
---|
3.4.22.B70 | Inhibition of SUMO-specific protease 1 induces apoptosis of astroglioma cells by regulating NF-kappaB/Akt pathways |
Homo sapiens |
3.4.22.B70 | SUMO protease SENP1 acts as a ceRNA for TGFBR2 and thus activates TGFBR2/Smad signaling responsible for LPS-induced sepsis |
Homo sapiens |
3.4.22.B70 | SUMO-specific cysteine protease 1 promotes epithelial mesenchymal transition of prostate cancer cells via regulating SMAD4 deSUMOylation |
Homo sapiens |
3.4.22.B70 | SUMO-specific protease 1 is critical for myeloid-derived suppressor cell development and function |
Mus musculus |
3.4.22.B70 | SUMO-specific protease 1 protects neurons from apoptotic death during transient brain ischemia/reperfusion |
Mus musculus |
3.4.22.B70 | The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion |
Homo sapiens |
3.4.22.B70 | The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression |
Homo sapiens |
3.4.22.B70 | 2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: Virtual screening, synthesis and biological evaluation |
Homo sapiens |
3.4.22.B70 | Biochemical characterization of the small ubiquitin-like modifiers of Chlamydomonas reinhardtii |
Homo sapiens |
3.4.22.B70 | Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1 |
Homo sapiens |